Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 01, 2015 12:16 PM ET

Professional Services

Company Overview of Agency for Science, Technology and Research

Company Overview

Agency for Science, Technology and Research provides economic oriented research to advance scientific discovery and develop innovative technology in Singapore. The company provides research services in the areas of biomedical sciences, including cancer genetics, stem cells and regenerative medicine, infectious disease and immunology, metabolic diseases, molecular cell and development biology, biomedical engineering, and platform technologies; and physical sciences and engineering, such as computational and device technologies, materials, chemistry, mechatronics and automation, manufacturing technology, metrology, and biotechnology, as well as information, communications, and media. It also o...

1 Fusionopolis Way

#20-10 Connexis North Tower

Singapore,  138632


Founded in 1990


65 6826 6111


65 6777 1711

Key Executives for Agency for Science, Technology and Research

Managing Director and Executive Director
Chief Scientist and Director of p53 Lab
Age: 62
Deputy Managing Director of Corporate & Legal and General Counsel
Chairman of Biomedical Research Council and Director
Age: 78
Executive Chairman of Exploit Technologies Pte Ltd
Age: 59
Compensation as of Fiscal Year 2015.

Agency for Science, Technology and Research Key Developments

Visterra Partners with Agency for Science, Technology and Research to Develop VIS513

Visterra, Inc. and the Drug Discovery & Development (D3) unit under the Agency for Science, Technology and Research, Singapore announced a collaboration to further the development of VIS513, Visterra's broadly neutralizing antibody for the treatment of dengue fever. VIS513, which was engineered using Visterra's innovative and proprietary technology, is a humanized monoclonal antibody that is designed to bind and potently neutralize all four serotypes of dengue virus. The company's preclinical studies of VIS513 in animal models have demonstrated a rapid reduction in viral titers after a single systemic administration, which supports its potential use as a single administration treatment for dengue virus infection. The collaboration combines Visterra's expertise in therapeutic antibodies for challenging infectious diseases with D3's proficiency in bringing early stage discoveries into clinical development. D3 and Visterra will also work together with infectious disease experts at Duke-National University of Singapore (Duke-NUS) to generate additional data necessary to initiate clinical trials of VIS513. Upon completion of these activities, D3 and Visterra will advance VIS513 through proof-of-concept clinical trials in humans, which will be conducted in Singapore. Under the terms of the collaboration agreement Visterra retains all rights to develop and commercialize VIS513 globally.

Agency for Science, Technology and Research Presents at FT Asia Pharma Healthcare Summit, May-20-2015 09:40 AM

Agency for Science, Technology and Research Presents at FT Asia Pharma Healthcare Summit, May-20-2015 09:40 AM. Venue: InterContinental, 80 Middle Road, Singapore, Singapore. Speakers: Benjamin Seet, Executive Director of Biomedical Research Council.

The Ministry of Trade and Industry Announces Board Appointments at A*Star, Effective April 1, 2015

The Ministry of Trade and Industry announced appointment changes at board of A*Star. A*Star will gain two members: Mr. Yee Ping Yi, Designate Deputy Secretary for Policy at the Ministry of Finance, and Ms. Tan Li San, Deputy Secretary for Industry and Information at the Ministry of Communications and Information. All appointments will take effect from April 1, 2015.

Similar Private Companies By Industry

Company Name Region
CPP Asia Pacific Pte. Ltd. Asia
ScienTec Consulting Pte Ltd Asia
Adaugeo Group Asia
FMS Associates Asia Pte Ltd Asia
Crossborder Research Pte Ltd Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agency for Science, Technology and Research, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at